Glenmark gets nod to make oral drug for COVID-19 treatment
Web Desk Glenmark Pharmaceuticals has received manufacturing and marketing approval from India’s drug regulator, for manufacturing FabiFlu the first oral Favipiravir-approved medication in India for
June 20, 2020
